MHRP and partners across four continents recently launched a new collaborative HIV cure research initiative called DELIVER, or Developing Leadership and Innovation in Viral Eradication Research.
MHRP is partnering with the Makerere University Walter Reed Project (MUWRP) in Uganda to conduct a novel HIV vaccine study called “RapidVax,” which recently started in March 2024. This study (RV591) combines experimental HIV vaccines with a novel dose escalation strategy with the goal of improving the body’s immune response.
MHRP, through an international collaboration, just launched a new study (RV584) in Tanzania to test novel long-acting bispecific antibody alone and in combination with another potent monoclonal antibody (mAb) to determine and compare safety and antiviral effects, or how effective these drugs are at reducing the amount of HIV in people living with HIV, both alone and in combination.
The African Cohort Study (AFRICOS) celebrated its 10th Anniversary on Wednesday 1st November, 2023, with a Research Symposium to review key findings from the study, share ongoing analyses, and discuss plans under the theme titled, “Progress and Future Directions.”